Treffer: Increasing tendency of urine protein is a risk factor for rapid eGFR decline in patients with CKD: A machine learning-based prediction model by using a big database.

Title:
Increasing tendency of urine protein is a risk factor for rapid eGFR decline in patients with CKD: A machine learning-based prediction model by using a big database.
Authors:
Inaguma D; Department of Internal Medicine, Fujita Health University Bantane Hospital-Nagoya, Japan., Kitagawa A; Department of Internal Medicine, Fujita Health University Bantane Hospital-Nagoya, Japan., Yanagiya R; Division of Medical Information Systems, Fujita Health University School of Medicine-Toyoake, Japan., Koseki A; IBM Research-Tokyo, Japan., Iwamori T; IBM Research-Tokyo, Japan., Kudo M; IBM Research-Tokyo, Japan., Yuzawa Y; Department of Nephrology, Fujita Health University School of Medicine-Toyoake, Japan.
Source:
PloS one [PLoS One] 2020 Sep 17; Vol. 15 (9), pp. e0239262. Date of Electronic Publication: 2020 Sep 17 (Print Publication: 2020).
Publication Type:
Journal Article
Language:
English
Journal Info:
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Imprint Name(s):
Original Publication: San Francisco, CA : Public Library of Science
References:
Crit Care Med. 2018 Jul;46(7):1070-1077. (PMID: 29596073)
PLoS One. 2015 May 20;10(5):e0127071. (PMID: 25992629)
Am J Kidney Dis. 2014 Feb;63(2):236-43. (PMID: 24182662)
Clin Exp Nephrol. 2017 Jun;21(3):446-456. (PMID: 27412450)
Am J Kidney Dis. 2019 Dec;74(6):803-810. (PMID: 31451330)
Am J Nephrol. 2012;36(1):1-10. (PMID: 22699366)
Kidney Int. 2012 Sep;82(5):516-24. (PMID: 22673882)
Kidney Int. 2006 Jan;69(2):375-82. (PMID: 16408129)
JAMA. 2019 Oct 1;322(13):1294-1304. (PMID: 31573641)
Am J Kidney Dis. 2014 Dec;64(6):821-35. (PMID: 25441437)
Clin Exp Nephrol. 2018 Dec;22(6):1331-1340. (PMID: 29869754)
Am J Kidney Dis. 2019 Sep;74(3):310-319. (PMID: 31031087)
Nat Biomed Eng. 2018 Oct;2(10):719-731. (PMID: 31015651)
J Am Coll Cardiol. 2018 Jun 12;71(23):2668-2679. (PMID: 29880128)
N Engl J Med. 2001 Sep 20;345(12):851-60. (PMID: 11565517)
Kidney Blood Press Res. 2018;43(6):1852-1864. (PMID: 30537719)
Am J Kidney Dis. 2010 Nov;56(5):896-906. (PMID: 20801567)
Am J Kidney Dis. 2016 Aug;68(2):219-228. (PMID: 26948835)
Kidney Int. 2016 Nov;90(5):1109-1114. (PMID: 27666758)
Contrib Nephrol. 2018;193:45-54. (PMID: 29393158)
N Engl J Med. 2019 Jun 13;380(24):2295-2306. (PMID: 30990260)
Kidney Int. 2016 Aug;90(2):422-429. (PMID: 27262365)
N Engl J Med. 2001 Sep 20;345(12):861-9. (PMID: 11565518)
Sci Rep. 2019 Mar 25;9(1):5082. (PMID: 30911092)
Adv Chronic Kidney Dis. 2011 Nov;18(6):420-7. (PMID: 22098660)
Kidney Int. 2018 Sep;94(3):567-581. (PMID: 30078514)
Metabolism. 2017 Apr;69S:S36-S40. (PMID: 28126242)
J Am Soc Nephrol. 2018 Nov;29(11):2755-2769. (PMID: 30314978)
Sci Rep. 2019 Jul 3;9(1):9583. (PMID: 31270387)
Math Biosci. 2019 Apr;310:24-30. (PMID: 30768948)
Cochrane Database Syst Rev. 2014 Jun 18;(6):CD007333. (PMID: 24938824)
JAMA. 2014 Jun 25;311(24):2518-2531. (PMID: 24892770)
J Transl Med. 2019 Apr 11;17(1):119. (PMID: 30971285)
Molecular Sequence:
figshare 10.6084/m9.figshare.12780311
Entry Date(s):
Date Created: 20200917 Date Completed: 20201105 Latest Revision: 20201105
Update Code:
20250114
PubMed Central ID:
PMC7497987
DOI:
10.1371/journal.pone.0239262
PMID:
32941535
Database:
MEDLINE

Weitere Informationen

Artificial intelligence is increasingly being adopted in medical fields to predict various outcomes. In particular, chronic kidney disease (CKD) is problematic because it often progresses to end-stage kidney disease. However, the trajectories of kidney function depend on individual patients. In this study, we propose a machine learning-based model to predict the rapid decline in kidney function among CKD patients by using a big hospital database constructed from the information of 118,584 patients derived from the electronic medical records system. The database included the estimated glomerular filtration rate (eGFR) of each patient, recorded at least twice over a period of 90 days. The data of 19,894 patients (16.8%) were observed to satisfy the CKD criteria. We characterized the rapid decline of kidney function by a decline of 30% or more in the eGFR within a period of two years and classified the available patients into two groups-those exhibiting rapid eGFR decline and those exhibiting non-rapid eGFR decline. Following this, we constructed predictive models based on two machine learning algorithms. Longitudinal laboratory data including urine protein, blood pressure, and hemoglobin were used as covariates. We used longitudinal statistics with a baseline corresponding to 90-, 180-, and 360-day windows prior to the baseline point. The longitudinal statistics included the exponentially smoothed average (ESA), where the weight was defined to be 0.9*(t/b), where t denotes the number of days prior to the baseline point and b denotes the decay parameter. In this study, b was taken to be 7 (7-day ESA). We used logistic regression (LR) and random forest (RF) algorithms based on Python code with scikit-learn library (https://scikit-learn.org/) for model creation. The areas under the curve for LR and RF were 0.71 and 0.73, respectively. The 7-day ESA of urine protein ranked within the first two places in terms of importance according to both models. Further, other features related to urine protein were likely to rank higher than the rest. The LR and RF models revealed that the degree of urine protein, especially if it exhibited an increasing tendency, served as a prominent risk factor associated with rapid eGFR decline.

DI received lecture fees from Ono Pharmaceutical Co., Ltd. and Kyowa Hakko Kirin Co. YY received research support grants from Otsuka Pharmaceutical Co., Ltd., Kyowa Hakko Kirin Co., Ltd., and Chugai Pharmaceutical Co., Ltd. IBM Research provided support for this study in the form of salaries for AK, TI and MK. There are no patents, products in development or marketed products associated with this research to declare. This does not alter our adherence to PLOS ONE policies on sharing data and materials.